Hematopoiesis and bone remodeling

Toshio Suda

doi:10.1182/blood-2011-03-344127

Hematopoiesis and bone remodeling

Toshio Suda

Research output: Contribution to journal › Comment/debate › peer-review

6 Citations (Scopus)

Abstract

Erythropoietin (Epo) is a polypeptide hormone produced in kidney. It stimulates the proliferation of erythroid progenitor cells in response to hypoxia. In this issue of Blood, the report of Singbrant et al clearly shows the indirect effect of Epo on bone remodeling and its importance for the Epo-induced erythropoietic response.¹ The finding adds a new dimension to the regulatory networks controlling eryropoiesis and bone remodeling.

Original language	English
Pages (from-to)	5556-5557
Number of pages	2
Journal	Blood
Volume	117
Issue number	21
DOIs	https://doi.org/10.1182/blood-2011-03-344127
Publication status	Published - 2011 May 26
Externally published	Yes

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2011-03-344127

Cite this

@article{65c909caadc94f278a4c423c0499eae5,

title = "Hematopoiesis and bone remodeling",

abstract = "Erythropoietin (Epo) is a polypeptide hormone produced in kidney. It stimulates the proliferation of erythroid progenitor cells in response to hypoxia. In this issue of Blood, the report of Singbrant et al clearly shows the indirect effect of Epo on bone remodeling and its importance for the Epo-induced erythropoietic response.1 The finding adds a new dimension to the regulatory networks controlling eryropoiesis and bone remodeling.",

author = "Toshio Suda",

year = "2011",

month = may,

day = "26",

doi = "10.1182/blood-2011-03-344127",

language = "English",

volume = "117",

pages = "5556--5557",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "21",

}

TY - JOUR

T1 - Hematopoiesis and bone remodeling

AU - Suda, Toshio

PY - 2011/5/26

Y1 - 2011/5/26

N2 - Erythropoietin (Epo) is a polypeptide hormone produced in kidney. It stimulates the proliferation of erythroid progenitor cells in response to hypoxia. In this issue of Blood, the report of Singbrant et al clearly shows the indirect effect of Epo on bone remodeling and its importance for the Epo-induced erythropoietic response.1 The finding adds a new dimension to the regulatory networks controlling eryropoiesis and bone remodeling.

AB - Erythropoietin (Epo) is a polypeptide hormone produced in kidney. It stimulates the proliferation of erythroid progenitor cells in response to hypoxia. In this issue of Blood, the report of Singbrant et al clearly shows the indirect effect of Epo on bone remodeling and its importance for the Epo-induced erythropoietic response.1 The finding adds a new dimension to the regulatory networks controlling eryropoiesis and bone remodeling.

UR - http://www.scopus.com/inward/record.url?scp=79957599986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957599986&partnerID=8YFLogxK

U2 - 10.1182/blood-2011-03-344127

DO - 10.1182/blood-2011-03-344127

M3 - Comment/debate

C2 - 21617007

AN - SCOPUS:79957599986

VL - 117

SP - 5556

EP - 5557

JO - Blood

JF - Blood

SN - 0006-4971

IS - 21

ER -

Hematopoiesis and bone remodeling

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this